Breithorn Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$5.16M Sell
38,992
-1,585
-4% -$194K 3.65% 9
2017
Q1
$5M Sell
40,577
-4,505
-10% -$533K 3.64% 11
2016
Q4
$4.97M Buy
45,082
+7,333
+19% +$815K 3.47% 12
2016
Q3
$4.46M Hold
37,749
3.34% 14
2016
Q2
$4.22M Buy
37,749
+1,712
+5% +$184K 3.23% 16
2016
Q1
$3.63M Buy
+36,037
New +$3.46M 2.51% 22

Other funds holding LH

Breithorn Capital Management's LH Position: Q2 2017 in Review

Breithorn Capital Management reduced its Labcorp (LH) stake by 3.9% in Q2 2017, selling an estimated $194K and leaving 38,992 shares worth $5.16M. The position accounts for 3.65% of the portfolio, ranked #9.

Breithorn Capital Management first reported a position in LH in Q1 2016 and has held it in 6 quarters since. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Breithorn Capital Management held 38,992 shares of Labcorp worth $5.16M as of Q2 2017.
  • Breithorn Capital Management sold 1,585 Labcorp shares in Q2 2017, an estimated $194K.
  • Labcorp made up 3.65% of Breithorn Capital Management's portfolio in Q2 2017, its #9 holding.
  • Breithorn Capital Management first reported a position in Labcorp in Q1 2016 and has held it in 6 quarters since.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Breithorn Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.